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Introduction
 Ovarian cancer continues to pose a major challenge 
to physicians and radiologists. It is third most common 
gynecologic malignancy (Silverberg et al., 1990; Tawani 
et al., 2005) and estimated to be the fifth leading cancer 
cause of death in women (Landis et al., 1998) after lung, 
breast, colon, and pancreatic cancer and constitutes 
23% of all gynecological malignancies (Woodward et 
al., 2004). Nearly two thirds of all ovarian carcinomas 
have progressed to disease stage III or IV at time of 
first diagnosis because they may remain clinically 
asymptomatic for extended periods (Nagell et al., 1990; 
Kombacher et al., 1992). The “silent” nature of disease 
and lack of established population-based screening 
programmes are the major factors why the majority of 
women present with advanced disease and consequently 
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Abstract
 Background: Ovarian cancer continues to pose a major challenge to physicians and radiologists. It is the 
third most common gynecologic malignancy and estimated to be fifth leading cancer cause of death in women, 
constituting 23% of all gynecological malignancies. Multi-detector computed tomography (MDCT) appears to 
offer an excellent modality in diagnosing ovarian cancer based on combination of its availability, meticulous 
technique, efficacy and familiarity of radiologists and physicians. The aim of this study was to compute sensitivity, 
specificity, positive and negative predictive values and diagnostic accuracy of 64- slice MDCT in classifying 
ovarian masses; 95% confidence intervals were reported. Materials and Methods: We prospectively designed 
a cross-sectional analytical study to collect data from July 2010 to August 2011 from a tertiary care hospital in 
Karachi, Pakistan. A sample of 105 women aged between 15-80 years referred for 64-MDCT of abdomen and 
pelvis with clinical suspicion of malignant ovarian cancer, irrespective of stage of disease, were enrolled by non-
probability purposive sampling. All patients who were already known cases of histologically proven ovarian 
carcinoma and having some contraindication to radiation or iodinated contrast media were excluded. Results: 
Our prospective study reports sensitivity, specificity; positive and negative predictive values with 95%CI and 
accuracy were computed. Kappa was calculated to report agreement among the two radiologists. For reader 
A, MDCT was found to have 92% (0.83, 0.97) sensitivity and 86.7% (0.68, 0.96) specificity, while PPV and NPV 
were 94.5% (0.86, 0.98) and 86.7% (0.63, 0.92), respectively. Accuracy reported by reader A was 90.5%. For 
reader B, sensitivity, specificity, PPV and NPV were 94.6% (0.86, 0.98) 90% (0.72, 0.97) 96% (0.88, 0.99) and 
87.1% (0.69, 0.95) respectively. Accuracy computed by reader B was 93.3%. Excellent agreement was found 
between the two radiologists with a significant kappa value of 0.887. Conclusion: Based on our study results, 
we conclude MDCT is a reliable imaging modality in diagnosis of ovarian masses accurately with insignificant 
interobserver variability. 
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have a poor prognosis. Seventy-six percent of patients 
with ovarian cancer survive only 1 year after diagnosis 
(Timpani et al., 2000).The incidence and mortality rates 
of ovarian cancer increases with age and for all stages, 
the 5-year survival rate is 45% (American Cancer Society, 
2007).
 Ovarian tumors are classified as epithelial tumors, 
germ cell tumors, sex cord–stromal cell tumors, and 
metastatic tumors on the basis of tumor origin (Koonings 
et al., 1989).As most patients with ovarian carcinoma have 
distant or widespread disease at the time of diagnosis, 
this fact underscores the importance of early detection 
and improved characterization of ovarian masses and is 
of paramount and utmost importance in the preoperative 
evaluation, enabling the surgeon to anticipate carcinoma 
of the ovary before the operation, so that adequate 
procedures are planned (Hermann et al., 1987; Mugel 
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et al., 1993; Osmers et al., 1996; Sengupta et al., 2000). 
Bimanual pelvic examination and serum CA-125 levels 
have failed to allow consistent detection of ovarian 
malignancy. Because the sensitivities of these techniques 
are often below 50%, imaging modalities have become 
indispensable (Jacobs et al., 1989; Taylor et al., 1994; 
Kurtz et al., 1999; Ferozabadi et al., 2011). Sonography 
has been shown to be a sensitive, but relatively nonspecific 
method, leading to unnecessary surgical resection of many 
benign lesions (Outwater et al., 1995). Besides clinical 
examination, CA 125 levels, and ultrasonography, CT 
scan is also used as a diagnostic technique for ovarian 
carcinoma and is superior to US in assessment of the nature 
of ovarian masses. It has proven as an excellent modality 
in the diagnosis of women believed to have ovarian cancer 
based on combination of its ready availability, meticulous 
technique, efficacy and familiarity of radiologists and 
physicians (Spencer et al., 2005). With the advent of 64- 
slice multidetector Computed Tomography (MDCT), it 
has become possible to acquire several thin slices and 
image reconstruction in axial, coronal and sagittal planes 
contributing valuable information towards preoperative 
surgical and management planning (Parish, 2007).
 
Materials and Methods
 A cross sectional analytical study was designed to 
collect data from the Department of Radiology, Aga Khan 
University Hospital Karachi from July 2010 to August 
2011. Female patients (age range 15-80 years) referred 
for 64-MDCT of Abdomen and pelvis with clinical 
suspicion of malignant ovarian cancer irrespective of 
stage of disease was included. Patients with signs and 
symptoms of weight loss, abdominal or pelvic mass 
detected on examination by physician deemed suspicious 
for ovarian cancer were included in the study. Patients 
who were already known case of histologically proven 
ovarian carcinoma and, having some contraindication 
to radiation or iodinated contrast media were excluded. 
MDCT scan of abdomen and pelvis performed from dome 
of the diaphragm to the pubic symphysis by 64 slice 
Aquilion, Toshiba Medical System at 120 kvp and 350 
mAs by a trained technologist with 5 years’ experience 
in MDCT scanning. All patients received intravenous 
non-ionic contrast medium omnipaque-300 (the dose of 
which was decided according to age and weight of the 
patient) and given by a computer-controlled injector at 
rate of 4 ml/second. First, volume data with 0.5 mm slice 
thickness were acquired in Porto-venous phase, followed 
by multiplanar reconstruction in axial, coronal and sagittal 
planes with a slice thickness of 5 mm each. MDCT 
reporting regarding presence of carcinoma ovary was 
done by consensus between two consultant radiologists 
with 5 and 8 years’ clinical experience in women imaging. 
Histopathological findings regarding malignancy were 
obtained from medical/histopathology records of patients. 
Data analysis procedure
 Data were entered and analyzed by utilizing SPSS 
windows package 19.0 version. Descriptive analysis was 
conducted i.e. frequencies and percentages for categorical 
variables like malignant (positive for ovarian carcinoma) 
or benign (negative for ovarian carcinoma) and mean and 
standard deviation for the continuous variables like age. 
 Sensitivity and Specificity of 64-slice MDCT were 
calculated and 95% Confidence Intervals (CI) reported. 
Positive, negative predictive values and accuracy 
were computed. The agreement between MDCT and 
histopathological findings for ovarian carcinoma was 
computed using kappa statistic between both readers. 
Sample size calculation
 Reported sensitivity of MDCT for the detection of 
ovarian carcinoma is 90% (Jain, 1994; Jung et al., 2002) 
taking confidence interval of 95%, bound on error of 6%, 
the calculated sample size N=97. We enrolled 106 patients 
in the study.
 n=Z2
1-α/2
-P(1-P)/B2
Results 
 During the study duration 105 women with a diagnosis 
of ovarian mass (mean age 53.13±SD 9.7 years) were 
enrolled in the study. Age range reported as 49 years, 
minimum and maximum 33, and 82 respectively. Out of 
105 ovarian lesions, 73 cases (69.5%) were read by First 
radiologist as malignant and 32 (30.5%) as benign.
 The second radiologist read 74 cases (70.5%) 
as malignant and 31 (29.5%) as benign. On later 
histopathological findings, 75 of 105 cases (71.4%) were 
proven to be malignant while 30 (28.6%) turned out to be 
benign. 
 Malignant lesions included Serous adenocarcinomas 
(n=32), mucinous adenocarcinomas (n=24), endometrioid 
carcinomas (n=12), malignant mullerian tumor (n=5) 
and Granulosa cell tumors (n=2). Benign lesions were 
endometriomas (n=15), benign cyst adenomas (n=5), 
teratomas (n=5), dermoid (n=3), corpus luteal cysts (n=2), 
simple ovarian cyst (n=1).
 In case of the first radiologist, there were four false 
positive cases: The first case on MDCT appeared as a 
predominantly solid lesion with patchy areas of necrosis. 
The interface with the adjacent fallopian tube was not 
clear and appeared adherent to it. On histology this 
mass proved to be degenerated subserosal fibroid. Since 
there was minimal amount of ascites associated with 
it as well, it was implicated as suspicious considering 
the post menopausal status of the patient. Amongst the 
other three patients two had multiple enhancing nodular 
peritoneal deposits with pelvic adhesions secondary to 
previous tuberculosis giving a bizarre appearance. One 
of the patients had endometrioma deposit near the broad 
ligament which was read as malignant. Three of these 
cases were also read as malignant by the second reader as 
well. All the four cases had associated mild to moderate 
ascites as additional finding which further raised suspicion 
for malignancy.
 There were six false negatives in case of first 
radiologist: Three of these cases were considered benign 
on account of their small size, all less than 4 cm. Two 
amongst these proved to be endometroid carcinoma. 
Amongst these three cases, one was falsely negative by 
Asian Pacific Journal of Cancer Prevention, Vol 14, 2013 2629
DOI:http://dx.doi.org/10.7314/APJCP.2013.14.4.2627
Ovarian Masses: Is Multi-detector Computed Tomography a Reliable Imaging Modality?
the second radiologist. The remaining three false negative 
cases were apparently simple cysts with internal septations 
which all proved to be mucinous adenocarcinomas. Two 
of these cases were read as negative for malignancy by the 
second reader as well. Thus, for the first reader there were 
69 true positives, 4 false positives, 26 true negative, and 
6 false negative results. For the second reader there were 
71 true positives, 3 false positives, 27 true negative, and 4 
false negative results on MDCT based assessment. Overall 
in case of first reader, MDCT was found to have 92%, 
95%CI (0.83,0.97) sensitivity, 86.7%, 95%CI (0.68,0.96) 
specificity, while PPV and NPV were 94.5%, 95%CI 
(0.86,0.98) and 86.7%, 95%CI (0.63,0.92), respectively.
(Table 1; Radiologist B).
 The sensitivity, specificity, PPV and NPV were 94.6%, 
95%CI (0.86,0.98) 90%, 95%CI (0.72,0.97) 96%, 95%CI 
(0.88,0.99) and 87.1%, 95%CI (0.69,0.95) respectively for 
the second reader (Table 1; Radiologist B).
 Kappa statistics for measure of agreement was 
calculated between both readers for MDCT findings. 
Excellent agreement was established between the two 
radiologists with a significant kappa value of 0.887. Very 
Good (k=0.771) and excellent (k=0.838) agreement was 
also found between the MDCT and histopathological 
findings for both readers with significant kappa values. 
 
Discussion
Ovarian malignancy usually has a delayed presentation 
due its non-specific symptoms. Most adnexal masses 
are suspected when patients presents with complaint 
of abdominal mass , or pain which later on is further 
evaluated by ultrasonography. Once we come across a 
neoplastic ovarian mass, it is imperative to decide whether 
the mass is benign or malignant to determine further 
treatment plan, and this is based largely on imaging 
appearances in addition to laboratory findings (Buy et al., 
1991; Parkin et al., 2005) 
The most commonly employed imaging modality for 
pelvic pathologies and adnexal masses is ultrasonography. 
Although it is the standard method for the preliminary 
assessment, due to its low cost, easy availability and high 
sensitivity of approximately 85-100%, it is still lagging 
behind CT and MRI due to its variable specificity rate 
(50-100%). On the other hand, the recent advances in CT 
technology has allowed better detection and improved 
role, not only in differentiation of benign and malignant 
ovarian masses, but also evaluation of metastatic deposits 
and extent of disease. Adequate determination of nature 
of mass and disease extent proves useful in planning of 
treatment which saves the patient unnecessary surgery and 
expense (Tamai et al., 2006; Tsili et al., 2008). 
The values of sensitivity and specificity of MDCT in 
differentiation of ovarian masses are comparable to those 
reported in literature (Kinkel et al., 2005; Tsili et al., 2008; 
Gatreh-Samani et al., 2011). A sensitivity and specificity 
of 81% and 87% has been reported by Kinkel et al. (2005) 
in their Meta-analysis. Similarly Tsili et al. have reported 
that MDCT can categorize adnexal masses into benign 
and malignant with a sensitivity and specificity of up to 
90.5% and 93.7% respectively. In our study, two separate 
radiologists recorded the MDCT findings. Overall in case 
of first reader, MDCT was found to have 92% sensitivity 
and 86.68% specificity, while the second reader reported 
a sensitivity and specificity 94.6%, 90% respectively. The 
difference between the results of two radiologists was not 
statistically significant. The relatively better results for 
the second reader could be related to the difference of 
experience between the two readers. Excellent agreement 
was found between the findings reported by the two 
readers and the histopathological results. Also, in our 
study all patients underwent biopsy (Gold-standard), 
thus minimizing verification bias and reporting accurate 
sensitivity rate.
With the advancement in technology and availability 
of MDCT with multiplanar reformation has resulted in 
significantly improved characterization of adnexal masses. 
One of the other advantages of MDCT is its fast 
acquisition in addition to providing a detailed evaluation 
of both adnexa and abdomen. The thin sections and high 
resolution provides good details of internal architecture of 
masses, leading to significantly improved characterization 
of adnexal masses and a reliable differentiation between 
benign and malignant ones. Moreover the near-isotropic 
imaging possible with a 64 slice MDCT enabled 
the acquisition of high resolution multiplanar and 
3D-reconstructed images. These acquisitions added to the 
detection of additional findings like ascites, invasion of 
pelvic viscera and pathological lymph nodes which further 
substantiated the confidence of readers in the diagnosis 
of malignancy. The ability to perform these thin section 
scans and reformatted images in different planes with 
spatial resolution similar to the original scanning plane 
has provided MDCT a pivotal role in staging and planning 
of further surgical management.
There are myriad types of ovarian masses and 
CT appearances vary widely. Accurate histologic 
characterization is thus not always possible however some 
tumors have certain radiologic features which predominate 
and knowledge of these key findings may help in reaching 
a specific diagnosis.
We in our study reported a diagnostic accuracy of 
90.5% and 96% respectively by reader A and B. These 
findings are comparable to those reported in literature 
(Kinkel et al., 2005; Gatreh et al., 2011).There were 
few false negative and false positive cases in this study. 
The presence of ascites in a post-menopausal patient 
with associated adnexal mass implicates possibility 
Table 1. Radiologist A and B
64-MDCT Gold-standard (Histopathology)
 Present (+ve) Absent (-ve)
Radiologist A:
  Present (+ve) True positive (a) 69
 False Positive (b)  4
  Absent (-ve) False Negative (c) 6
 True Negative (d)  26
Radiologist B:
  Present (+ve) True positive (a) 71
 False Positive (b)  3
  Absent (-ve) False Negative (c) 4
 True Negative (d)  27
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of malignancy. The presence of these findings made 
it difficult to exclude malignancy leading to false 
positives. Cysts smaller than 4 cm containing smooth 
non enhancing internal septations is a characteristic of 
benign lesion, however few such cases turned out to be 
mucinous adenocarcinomas on histopathology in our 
study population. Previously studies (Tsili et al., 2008; 
Adel et al., 2011; Satoh et al., 2011) have been carried 
out on same topic; however no interobeserver agreement 
was calculated. 
This study had a few limitations as well. First, all 
the patients sent for MDCT were included in the study 
which could result in selection bias. Patient population 
for ovarian lesions were relatively small.
In conclusion, based on our study we can conclude 
that MDCT is a reliable imaging modality in diagnosis 
of ovarian masses accurately and with insignificant 
interobserver variability.
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